ESR1 and breast cancer: In addition, the absence of specific receptors on the BC cell surface (estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2)) results in the impossibility of molecularly targeted treatment [5,6,7], which significantly limits the possible therapies that can be applied.